Position in VCYT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$10,279,746
+$4,784,624 QoQ
Shares Held
175,034
+2.6% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#62
of 367 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Palisades Investment Partners, LLC holds $11,453,317 across 2 Diagnostics & Research names. VCYT ranks #1 (89.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
This page
|
175,034 | $10,279,746 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
2,216 | $1,173,571 |
All Filings in VCYT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,279,746 | 175,034 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $5,495,122 | 170,603 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,822,010 | 162,043 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $5,429,049 | 158,143 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $4,389,888 | 162,408 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,955,760 | 167,142 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $6,486,836 | 163,809 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||